Lamotrigin Stada

Lamotrigine, the active ingredient in Lamotrigin Stada, is an anticonvulsant presented as an oral tablet for oral use. Classified under ATC code N03AX12, it is prescribed for the management of epilepsy, bipolar disorder, and migraine prevention in adult patients. It is widely used across Europe and other regions.

GNH USA supplies Lamotrigin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to strict quality standards and regulatory requirements, and providing the product for both acute and maintenance therapy.

Lamotrigine is an anticonvulsant that is used in several neurological and psychiatric conditions.

- Epilepsy: reduces seizure frequency and helps achieve seizure control. - Bipolar disorder: stabilizes mood and decreases the frequency of manic and depressive episodes. - Migraine prophylaxis: lowers the number of migraine attacks when taken regularly.

Lamotrigine may cause a range of adverse reactions, which are categorised by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Headache: mild to moderate pain in the head. - Nausea: feeling of stomach upset or urge to vomit. - Rash: mild skin redness or itching. - Fatigue: feeling of tiredness or lack of energy. - Blurred vision: temporary loss of visual clarity.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Aseptic meningitis: inflammation of the meninges without infection, presenting with fever and neck stiffness. - Blood dyscrasias: including agranulocytosis or severe neutropenia.

When prescribing Lamotrigin Stada, clinicians should observe several safety measures.

- Initiate therapy at low dose: start with a low dose and increase gradually to reduce rash risk. - Monitor skin reactions: discontinue immediately if a widespread rash or signs of Stevens‑Johnson syndrome appear. - Assess hepatic function: use caution in patients with liver impairment and adjust monitoring. - Avoid abrupt discontinuation: taper the dose under medical supervision to prevent seizure worsening. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Lamotrigin Stada can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma levels, raising risk of toxicity. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine levels, may lead to loss of seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, requiring dose adjustment. - Serotonergic agents: combined use may increase risk of serotonin syndrome, monitor symptoms. - Antifungal azoles (e.g., fluconazole): can modestly raise lamotrigine concentrations, watch for side effects.